In metastatic osteosarcoma cells, a pro-inflammatory pathway has been identified that promotes anoikis resistance: the IL-8/C-X-C chemokine receptor (CXCR) 1/Akt-signaling pathway. This evidence concerns the gene CXCL8 and osteosarcoma.